Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Impact of new criteria for anticoagulant treatment in atrial fibrillation Rodriguez-Manero M; Cordero A; Bertomeu-Gonzalez V; Moreno-Arribas J; Bertomeu-Martinez V; Mazon P; Facila L; Cosin J; Lekuona I; Galve E; Gonzalez-Juanatey JRRev Esp Cardiol 2011[Aug]; 64 (8): 649-53INTRODUCTION AND OBJECTIVES: The guidelines for the management of atrial fibrillation (AF) incorporate new risk factors for thromboembolism, trying to de-emphasize the use of the 'low', 'moderate', and 'high' risk categories. The objective of this study was to determine the impact of the new scheme CHA(2)DS(2)-VASc and of the new recommendations for oral anticoagulation (OAC) in a contemporary sample of patients with AF seen by primary physicians and cardiologists. METHODS: Multicenter, observational, cross-sectional study on the epidemiology of hypertension and its control, designed by the arterial hypertension department. Each researcher enrolled the first 6 consenting patients who came for examination during a 5-day period. RESULTS: Of 25 137 individuals recruited, 1544 were diagnosed with AF. The vast majority of the sample had a CHADS(2) score >/=2 (77.3%). Individuals with a risk score lower than 2 were categorized according to the CHA(2)DS(2)-VASc score: 14.4% were aged 75 years or older (CHA(2)DS(2)-VASc=2). Of those younger than 75, 42.3% had a CHA(2)DS(2)-VASc=2; 23.7% CHA(2)DS(2)-VASc=3, and 1.1% CHA(2)DS(2)-VASc=4. This means that the 85.1% of the patients with a CHADS(2) score <2 and no contraindications are indicated for OAC. CONCLUSIONS: The new recommendations will result in a significant increase in patients with indications for OAC, at the expense of those previously characterized as low-to-moderate risk. Therefore, patients at risk of thromboembolic events must be identified, although an evaluation of bleeding risk should be part of the patient assessment before starting anticoagulation.|Aged[MESH]|Anticoagulants/*therapeutic use[MESH]|Atrial Fibrillation/*complications[MESH]|Cross-Sectional Studies[MESH]|Female[MESH]|Humans[MESH]|Hypertension/drug therapy/etiology[MESH]|Male[MESH]|Middle Aged[MESH]|Practice Guidelines as Topic[MESH]|Risk Factors[MESH]|Thromboembolism/*etiology/*prevention & control[MESH] |
